Back to Journals » Clinical Optometry » Volume 16

Response to “Vision-Related Quality of Life Among Diabetic Retinopathy Patients” [Letter]

Authors Nugroho HSW , Melati N, Intening VR

Received 20 May 2024

Accepted for publication 3 June 2024

Published 6 June 2024 Volume 2024:16 Pages 143—144

DOI https://doi.org/10.2147/OPTO.S479049

Checked for plagiarism Yes

Editor who approved publication: Mr Simon Berry



Heru Santoso Wahito Nugroho,1 Nimsi Melati,2 Vivi Retno Intening2

1Center of Excellence of Community Empowerment in Health, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia; 2Nursing Department, STIKes Bethesda Yakkum, Yogyakarta, Indonesia

Correspondence: Nimsi Melati; Vivi Retno Intening, Nursing Department, STIKes Bethesda Yakkum, Jl. Johar Nurhadi 6, Yogyakarta, DIY, 55224, Indonesia, Email [email protected]; [email protected]


View the original paper by Dr Mohamed and colleagues

A Response to Letter has been published for this article.


Dear editor

We have carefully read the article published under the title “Vision-Related Quality of Life Among Diabetic Retinopathy Patients in a Hospital-Based Population in the Sultanate of Oman”. The findings of this study have provided very valuable information that diabetic retinopathy has a significant impact on quality of life both overall and specifically according to various aspects. Researchers have proven that the stage of diabetic retinopathy not only affects overall quality of life, but also each of the twelve quality aspects studied, namely general health, general vision, ocular pain, near vision, distant vision, peripheral vision, social functioning, color vision, driving, role difficulties, mental health and independence.1 These findings suggest that the care of patients with diabetic retinopathy should not only focus on the medical problem, but also maintain the patient’s quality of life.

However, we believe that before analyzing the influence of diabetic retinopathy stage on a patient’s quality of life, ideally an analysis should first be carried out aimed at confirming whether the twelve aspects mentioned above are appropriate indicators for quality of life in general. This can be done using confirmatory factor analysis (CFA).2 Because researchers use numerical data, one statistical program that is suitable as an analysis tool is AMOS, but other programs can also be used.3 After confirming that these twelve aspects were appropriate indicators of the patient’s quality of life, the researchers continued with an analysis of the influence of the stage of diabetic retinopathy on overall quality of life and each specific aspect.

Therefore, we respectfully request that the editor give researchers the opportunity to carry out confirmatory factor analysis to ensure the accuracy of these twelve aspects as indicators of overall quality of life, then the results can be published in this journal as a response to our letter.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Mohamed Z, Vankudre GS, Ayyappan JP, et al. Vision-related quality of life among diabetic retinopathy patients in a hospital-based population in the Sultanate of Oman. Clin Optom. 2024;16:123–129. doi:10.2147/OPTO.S462498

2. Tavakol M, Wetzel A. Factor analysis: a means for theory and instrument development in support of construct validity. Int J Med Educ. 2020;11:245–247. doi:10.5116/ijme.5f96.0f4a

3. Alnaami N, Al Haqwi A, Masuadi E. Clinical learning evaluation questionnaire: a confirmatory factor analysis. Adv Med Educ Pract. 2020;11:953–961. doi:10.2147/AMEP.S243614

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.